La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Vivos a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Vivos..

Vivos (OTC:RDGL) Azioni, Catena delle Opzioni

Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising highly insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. IsoPet is another product of the company used for the treatment of solid tumors in animals. The company derives revenue through sales of its products.

Vivos Inc

<p>Keefe, Bruyette &amp; Woods  analyst Kyle Voigt   maintains Carlyle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>) with a Market Perform and raises the price target from $51 to $55.</p>


News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Market Perform on Carlyle Group, Raises Price Target to $55

<h3>Gainers</h3>
<ul>
<li><strong>Universal Electronics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UEIC#NASDAQ">UEIC</a>) stock increased by 30.8% to $11.01 during Friday's regular session. The market value of their outstanding shares is at $142.9 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Canoo</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) shares increased by 23.35% to $0.51. The market value of their outstanding shares is at $43.9 million. </li>
<li><strong>Potbelly</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBPB#NASDAQ">PBPB</a>) stock rose 22.49% to $10.13. The market value of their outstanding shares is at $302.2 million. The company's, Q3 earnings came out yesterday. </li>
<li><strong>Cango</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) shares increased by 21.62% to $3.6. The market value of their outstanding shares is at $375.7 million. As per the press release, Q3 earnings came out 4 days ago. </li>
<li><strong>Xponential Fitness</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) shares increased by 20.23% to $15.27. The company's market cap stands at $489.9 million. The company's, Q3 earnings came out yesterday. </li>
<li><strong>Lottery.com</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) shares moved upwards by 17.07% to $0.34. The company's market cap stands at $3.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Nxu</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXU#NASDAQ">NXU</a>) stock decreased by 45.5% to $0.29 during Friday's regular session. The company's market cap stands at $3.4 million. </li>
<li><strong>FIGS</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) stock fell 29.02% to $4.74. The market value of their outstanding shares is at $809.0 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>One Group Hospitality</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) stock decreased by 17.1% to $3.25. The company's market cap stands at $101.2 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Serve Robotics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) stock decreased by 15.75% to $9.12. The market value of their outstanding shares is at $391.5 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Fossil Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSL#NASDAQ">FOSL</a>) stock decreased by 13.39% to $1.1. The market value of their outstanding shares is at $58.2 million. The company's, Q3 earnings came out yesterday. </li>
<li><strong>Under Armour</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) shares declined by 11.51% to $9.85. The market value of their outstanding shares is at $4.2 billion. The company's, Q2 earnings came out yesterday.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Movers

CANG

FIGS

FOSL

GOEV

LTRY

PBPB

SERV

STKS

UEIC

XPOF

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>Tivic Health Systems</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) stock rose 39.8% to $0.36 during Friday's regular session. The market value of their outstanding shares is at $2.2 million. </li>
<li><strong>Fortrea Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) stock increased by 33.57% to $24.11. The market value of their outstanding shares is at $2.1 billion. As per the press release, Q3 earnings came out today. </li>
<li><strong>Rigel Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) stock moved upwards by 32.05% to $20.39. The market value of their outstanding shares is at $358.7 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li><strong>Inotiv</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) shares increased by 21.59% to $3.2. The company's market cap stands at $83.1 million. </li>
<li><strong>Bionomics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) stock rose 19.31% to $0.45. The market value of their outstanding shares is at $6.0 million. </li>
<li><strong>Inhibikase Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKT#NASDAQ">IKT</a>) stock increased by 18.7% to $3.3. The company's market cap stands at $217.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>ProPhase Labs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) stock fell 48.1% to $0.74 during Friday's regular session. The market value of their outstanding shares is at $14.1 million. </li>
<li><strong>Evolent Health</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) stock fell 41.11% to $14.47. The company's market cap stands at $1.6 billion. The company's, Q3 earnings came out yesterday. </li>
<li><strong>Maravai LifeSciences</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) shares fell 37.31% to $4.92. The market value of their outstanding shares is at $695.7 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Revance Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) stock fell 36.6% to $3.67. The company's market cap stands at $381.8 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Agilon Health</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) stock declined by 32.08% to $1.9. The market value of their outstanding shares is at $779.7 million. The company's, Q3 earnings came out yesterday. </li>
<li><strong>AlloVir</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVR#NASDAQ">ALVR</a>) stock decreased by 29.23% to $0.69. The market value of their outstanding shares is at $80.1 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ALVR

BNOX

FTRE

MRVI

NOTV

PRPH

RIGL

RVNC

TIVC

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>Northann</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock moved upwards by 70.5% to $0.38 during Friday's regular session. The company's market cap stands at $11.0 million. </li>
<li><strong>Innodata</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) shares rose 50.1% to $36.53. The company's market cap stands at $1.0 billion. The company's, Q3 earnings came out yesterday. </li>
<li><strong>TaskUs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TASK#NASDAQ">TASK</a>) stock increased by 22.72% to $19.08. The company's market cap stands at $1.6 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li><strong>American Superconductor</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>) shares increased by 19.56% to $33.85. The company's market cap stands at $1.3 billion. </li>
<li><strong>Bloom Energy</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) stock rose 18.13% to $12.61. The market value of their outstanding shares is at $2.8 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Axon Enterprise</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) stock moved upwards by 17.08% to $548.82. The market value of their outstanding shares is at $41.4 billion. As per the press release, Q3 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Nature's Miracle Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) shares fell 38.6% to $0.09 during Friday's regular session. The market value of their outstanding shares is at $2.8 million. </li>
<li><strong>Pixie Dust Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXDT#NASDAQ">PXDT</a>) shares declined by 31.29% to $0.47. The company's market cap stands at $7.0 million. </li>
<li><strong>Earlyworks Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) stock fell 26.17% to $4.98. The market value of their outstanding shares is at $15.0 million. </li>
<li><strong>CDT Environmental</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTG#NASDAQ">CDTG</a>) shares declined by 22.83% to $3.11. The market value of their outstanding shares is at $33.2 million. </li>
<li><strong>Blink Charging</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) stock decreased by 19.66% to $1.61. The company's market cap stands at $163.3 million. The company's, Q3 earnings came out yesterday. </li>
<li><strong>FREYR Battery</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FREY#NYSE">FREY</a>) shares decreased by 18.73% to $1.91. The company's market cap stands at $266.8 million. The company's, Q3 earnings came out 2 days ago.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AMSC

AXON

BLNK

CDTG

ELWS

FREY

INOD

Nuveen Insured California Premium Fund Ii

NMHI

PXDT

TASK

12 Industrials Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li><strong>FOXO Technologies</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) shares rose 114.5% to $0.79 during Friday's regular session. The company's market cap stands at $10.7 million. </li>
<li><strong>Porch Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) stock rose 52.78% to $3.56. The company's market cap stands at $357.6 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li><strong>Indie Semiconductor</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) shares moved upwards by 38.44% to $4.75. The market value of their outstanding shares is at $851.7 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Applied Optoelectronics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) shares increased by 37.88% to $24.68. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Expensify</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) stock increased by 31.31% to $2.6. The market value of their outstanding shares is at $228.5 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>EMCORE</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMKR#NASDAQ">EMKR</a>) shares increased by 28.05% to $3.04. The company's market cap stands at $27.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Lantronix</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>) shares decreased by 31.4% to $2.67 during Friday's regular session. The market value of their outstanding shares is at $100.5 million. As per the press release, Q1 earnings came out yesterday. </li>
<li><strong>nLight</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) stock fell 19.62% to $11.8. The company's market cap stands at $567.8 million. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>Sprout Social</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) stock fell 16.88% to $25.77. The market value of their outstanding shares is at $1.4 billion. The company's, Q3 earnings came out yesterday. </li>
<li><strong>Adeia</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADEA#NASDAQ">ADEA</a>) stock declined by 16.15% to $11.81. The company's market cap stands at $1.2 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li><strong>LivePerson</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPSN#NASDAQ">LPSN</a>) shares decreased by 14.47% to $1.03. The company's market cap stands at $92.1 million. The company's, Q3 earnings came out yesterday. </li>
<li><strong>SEMrush Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) shares declined by 13.17% to $12.4. The company's market cap stands at $1.8 billion. As per the news, the Q3 earnings report came out yesterday.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AAOI

ADEA

EMKR

EXFY

FOXO

INDI

LASR

LPSN

LTRX

PRCH

SEMR

12 Information Technology Stocks Moving In Friday's Intraday Session

<p>JP Morgan  analyst Rajat Gupta   maintains Cars.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARS#NYSE">CARS</a>) with a Neutral and raises the price target from $20 to $21.</p>


CARS

JP Morgan Maintains Neutral on Cars.com, Raises Price Target to $21

<p>- Reuters Citing Energy Department&nbsp;</p>


Macro Economic Events

Economics

U.S. Buys 2.4M Barrels Of Oil For SPR For Delivery To Texas Site In April Through May 2025; Biden Administration Buys Its Last Batch Of Oil To Refill Strategic Petroleum Reserve As Revenue From 2022 Sale Runs Out

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Taiwan Semiconductor</strong>.</p>
<p>Looking at options history for Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) we detected 51 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish expectations and 39% with bearish.</p>
<p>From the overall spotted trades, 9 are puts, for a total amount of $458,228 and 42, calls, for a total amount of $3,377,517.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $230.0 for Taiwan Semiconductor over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Taiwan Semiconductor's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Taiwan Semiconductor's whale trades within a strike price range from $90.0 to $230.0 in the last 30 days. </p>
<h3>Taiwan Semiconductor Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731083442_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.6</td>
<td>$16.35</td>
<td>$16.55</td>
<td>$200.00</td>
<td>$331.0K</td>
<td>25.3K</td>
<td>203</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$4.4</td>
<td>$4.35</td>
<td>$4.4</td>
<td>$197.50</td>
<td>$220.0K</td>
<td>5.4K</td>
<td>2.4K</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/08/24</td>
<td>$4.05</td>
<td>$3.85</td>
<td>$3.95</td>
<td>$197.50</td>
<td>$197.1K</td>
<td>5.4K</td>
<td>3.5K</td>
</tr>
<tr>
<td>TSM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$6.8</td>
<td>$6.75</td>
<td>$6.8</td>
<td>$155.00</td>
<td>$165.9K</td>
<td>802</td>
<td>260</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$4.75</td>
<td>$4.6</td>
<td>$4.75</td>
<td>$197.50</td>
<td>$161.0K</td>
<td>5.4K</td>
<td>1.9K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Taiwan Semiconductor</h3>
<p>Taiwan Semiconductor Manufacturing Co. is the world's largest dedicated chip foundry, with over 60% market share. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the us in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD, and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs. TSMC employs more than 73,000 people.</p>
<p>Following our analysis of the options activities associated with Taiwan Semiconductor, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Taiwan Semiconductor</h3>
<ul>
<li>With a trading volume of 14,526,196, the price of TSM is up by 4.09%, reaching $201.13.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 69 days from now.</li>
</ul>
<h3>Expert Opinions on Taiwan Semiconductor</h3>
<p>3 market experts have recently issued ratings for this stock, with a consensus target price of $216.66666666666666.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $210.<br />
&#x2A; Consistent in their evaluation, an analyst from Needham keeps a Buy rating on Taiwan Semiconductor with a target price of $225.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on Taiwan Semiconductor, maintaining a target price of $215. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Taiwan Semiconductor options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Markets

Taiwan Semiconductor's Options: A Look at What the Big Money is Thinking

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Baidu</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BIDU, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 19 uncommon options trades for Baidu.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 52% bullish and 36%, bearish.</p>
<p>Out of all of the special options we uncovered, 3 are puts, for a total amount of $222,741, and 16 are calls, for a total amount of $879,853.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $115.0 for Baidu, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Baidu's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Baidu's substantial trades, within a strike price spectrum from $70.0 to $115.0 over the preceding 30 days.</p>
<h3>Baidu Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731083437_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$6.1</td>
<td>$5.8</td>
<td>$6.0</td>
<td>$100.00</td>
<td>$300.6K</td>
<td>1.8K</td>
<td align="right">507</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$5.65</td>
<td>$5.55</td>
<td>$5.6</td>
<td>$90.00</td>
<td>$140.0K</td>
<td>4.1K</td>
<td align="right">913</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.95</td>
<td>$5.9</td>
<td>$5.95</td>
<td>$100.00</td>
<td>$59.5K</td>
<td>1.8K</td>
<td align="right">616</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$20.9</td>
<td>$20.7</td>
<td>$20.9</td>
<td>$70.00</td>
<td>$58.5K</td>
<td>249</td>
<td align="right">29</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.1</td>
<td>$3.95</td>
<td>$4.1</td>
<td>$85.00</td>
<td>$55.7K</td>
<td>7.2K</td>
<td align="right">161</td>
</tr>
</tbody>
</table>
</p>
<h3>About Baidu</h3>
<p>Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.</p>
<p>In light of the recent options history for Baidu, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Baidu Standing Right Now?</h3>
<ul>
<li>With a volume of 1,822,533, the price of BIDU is down -4.74% at $89.09. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 13 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Baidu, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


BIDU

Decoding Baidu's Options Activity: What's the Big Picture?

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>T-Mobile US</strong>.</p>
<p>Looking at options history for T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) we detected 20 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and 50% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $273,000 and 18, calls, for a total amount of $838,335.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $150.0 to $230.0 for T-Mobile US during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in T-Mobile US's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to T-Mobile US's substantial trades, within a strike price spectrum from $150.0 to $230.0 over the preceding 30 days.</p>
<h3>T-Mobile US Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1731083431_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TMUS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$4.7</td>
<td>$4.4</td>
<td>$4.55</td>
<td>$230.00</td>
<td>$227.5K</td>
<td align="right">565</td>
<td align="right">506</td>
</tr>
<tr>
<td>TMUS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$83.35</td>
<td>$82.1</td>
<td>$82.1</td>
<td>$165.00</td>
<td>$123.2K</td>
<td align="right">1</td>
<td align="right">15</td>
</tr>
<tr>
<td>TMUS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$90.0</td>
<td>$88.35</td>
<td>$88.35</td>
<td>$155.00</td>
<td>$61.9K</td>
<td align="right">204</td>
<td align="right">7</td>
</tr>
<tr>
<td>TMUS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$83.85</td>
<td>$82.75</td>
<td>$83.85</td>
<td>$160.00</td>
<td>$58.7K</td>
<td align="right">590</td>
<td align="right">7</td>
</tr>
<tr>
<td>TMUS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$56.35</td>
<td>$56.3</td>
<td>$56.35</td>
<td>$185.00</td>
<td>$56.3K</td>
<td align="right">570</td>
<td align="right">10</td>
</tr>
</tbody>
</table>
</p>
<h3>About T-Mobile US</h3>
<p>Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 77 million postpaid and 21 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves more than 5 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.</p>
<h3>Current Position of T-Mobile US</h3>
<ul>
<li>With a trading volume of 813,356, the price of TMUS is up by 1.81%, reaching $235.67.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 76 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for T-Mobile US</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $248.2.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on T-Mobile US, which currently sits at a price target of $254.<br />
&#x2A; Consistent in their evaluation, an analyst from Scotiabank keeps a Sector Perform rating on T-Mobile US with a target price of $237.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on T-Mobile US, which currently sits at a price target of $240.<br />
&#x2A; An analyst from UBS persists with their Buy rating on T-Mobile US, maintaining a target price of $255.<br />
&#x2A; An analyst from Benchmark has decided to maintain their Buy rating on T-Mobile US, which currently sits at a price target of $255. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for T-Mobile US with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


TMUS

Smart Money Is Betting Big In TMUS Options

<p>HC Wainwright &amp; Co.  analyst Douglas Tsao   reiterates Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) with a Buy and maintains $14 price target.</p>


Reiteration

RZLT

HC Wainwright & Co. Reiterates Buy on Rezolute, Maintains $14 Price Target

<p>JP Morgan  analyst Jeffrey Zekauskas   maintains Air Products &amp; Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) with a Overweight and lowers the price target from $350 to $345.</p>


JP Morgan Maintains Overweight on Air Products & Chemicals, Lowers Price Target to $345

<p>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) (Pineapple Energy) ("Pineapple" or the "Company"), a leading provider of sustainable solar energy and backup power to households, businesses, municipalities, and for servicing existing systems, today announced that it is changing its corporate name to SUNation Energy, Inc. ("SUNation").&nbsp;The effective date for the name change will be announced in the near term.</p>
<p>The corporate name change and a proposal to approve the redomestication and change in the Company's legal state of incorporation from Minnesota to Delaware were each overwhelmingly approved at a Special Meeting of Shareholders held on November 4, 2024.&nbsp;&nbsp;&nbsp;</p>


PEGY

Pineapple Energy Shareholders Approve Incorporation To Delaware And New Corporate Name Change To SUNation Energy, Inc.; The Effective Date For The Name Change Will Be Announced In The Near Term.

<p>Oppenheimer  analyst Jeff Jones   reiterates Ventyx Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTYX#NASDAQ">VTYX</a>) with a Outperform and lowers the price target from $10 to $9.</p>


VTYX

Oppenheimer Reiterates Outperform on Ventyx Biosciences, Lowers Price Target to $9

<p>Jefferies  analyst Yaron Kinar   maintains Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) with a Buy and raises the price target from $231 to $267.</p>


Jefferies Maintains Buy on Allstate, Raises Price Target to $267

Management

QDEL

QuidelOrtho Determined To Terminate Employment Of Michael S. Iskra, Co's Executive VP And Chief Commercial Officer And Robert J. Bujarski, Co's EVP And Chief Operating Officer

<p>Oppenheimer  analyst Andrew Uerkwitz   reiterates Turtle Beach (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEAR#NASDAQ">HEAR</a>) with a Outperform and raises the price target from $17 to $20.</p>


HEAR

Oppenheimer Reiterates Outperform on Turtle Beach, Raises Price Target to $20

<p>Oppenheimer  analyst Jason Helfstein   maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Outperform and raises the price target from $120 to $135.</p>


Oppenheimer Maintains Outperform on Trade Desk, Raises Price Target to $135

<p>Crypto analyst Benjamin Cowen suggests that <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dominance might continue climbing, even as it hits his long-standing 60% target, following the <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">Fed's recent 25 basis point interest rate cut</a>.</p>
<p><strong>What Happened:</strong> In an update on his YouTube <a href="https://youtu.be/NPu6mfY_Pz8?si=35Qnt5mVElqCe9nx">channel</a>, Cowen analyzed the Federal Reserve's <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41820253/fed-cuts-interest-rates-to-lowest-since-february-2023-sticks-to-data-driven-path">decision to reduce rates</a> to lowest level since February 2023 and maintain quantitative tightening by continuing to reduce its holdings in Treasury securities and mortgage-backed securities.</p>
<p>He highlighted that Bitcoin's dominance has typically peaked (60%) only after quantitative easing (QE) starts. This time, he sees two possible scenarios: Bitcoin dominance could begin a topping process, or it might overshoot its peak before settling back.</p>
<p>He also emphasized monitoring <strong>Ethereum's </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) performance against Bitcoin, as it plays a key role in dominance trends. Cowen recommended dollar-cost averaging in altcoins as the market heads into the post-halving phase.</p>
<p>Quoting the Federal Reserve&#8217;s press release, Cowen highlighted that the committee plans to "continue reducing its Holdings of Treasury Securities and agency debt and agency mortgage-backed Securities." He stressed the potential influence of this decision on the crypto market.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure></p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41841793/bitcoin-ethereum-solana-rally-does-not-mean-all-cryptocurrencies-will-moon-10x-research">Bitcoin, Ethereum, Solana Rally Does Not Mean All Cryptocurrencies Will Moon: 10x Research</a></strong></p>
<p><strong>Why It Matters: </strong>Despite his cautious outlook, Cowen anticipates Bitcoin will adhere to its cyclical behaviour. He warned, however, that a broader market correction could interrupt these patterns, impacting both Bitcoin and altcoins.</p>
<p>The Federal Reserve&#8217;s decision to lower interest rates has slowed the pace of rate cuts compared to September, when policymakers opted for a more substantial 0.5% cut to initiate the easing cycle.</p>
<p>A senior research strategist noted that that the Fed's gradual cuts toward a "neutral" 3% rate could be partly due to Trump's policies, including tariffs, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41824236/feds-interest-rate-cut-pace-expected-to-slow-economists-weigh-trumps-white-house-re">which may have a reflationary effect</a>.</p>
<p><strong>What&#8217;s Next</strong>: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41807557/bitcoin-as-americas-gold-trumps-bitcoin-act-could-reshape-us-reserves-says-coinshares">Bitcoin As America&#8217;s Gold? How Trump&#8217;s Bitcoin Act Could Reshape US Reserves</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Federal Reserve Cuts Interest Rates—Bitcoin Dominance May Rise As A Result

<p>Oppenheimer  analyst Michael Wiederhorn   maintains Pennant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNTG#NASDAQ">PNTG</a>) with a Outperform and raises the price target from $34 to $37.</p>


PNTG

Oppenheimer Maintains Outperform on Pennant Gr, Raises Price Target to $37

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>I cannot stress enough how risky OTC stocks or securities traded over the counter really are. For one thing, just the name OTC should ring some alarm bells. This designation means that these securities don&rsquo;t trade on exchanges like the <strong>New York Stock Exchange</strong> or the <strong>Nasdaq</strong>. Instead, they trade via broker-dealer networks. And not all stock platforms support what&rsquo;s otherwise known as the pink sheets.</p>



<p>Second, many investors are shocked to discover the administrative costs tied to OTC stocks. Yes, many of these securities are &ldquo;cheap,&rdquo; trading hands at unit prices well below a buck. However, that doesn&rsquo;t mean that it&rsquo;s cheap to <em>you</em>. Wide bid-ask spreads may mean that your holdings may have to rise significantly higher to be net profitable. Also, even if you are profitable, low trading volume could mean a long time to find a buyer.</p>



<p>At the same time, OTC stocks or otherwise highly speculative shares can fly higher. Some <a href="https://www.gobankingrates.com/investing/stocks/most-successful-penny-stocks-ever/">examples</a> include the following:</p>



<ul><li><strong>Monster Beverage</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/mnst-stock-quote/"><strong>MNST</strong></a>): In 1997, you could have had MNST for just two cents.</li>



<li><strong>Apple</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/aapl-stock-quote/"><strong>AAPL</strong></a>): On a split-adjusted basis, you could have bought AAPL for 10 cents in December 1980.</li>



<li><strong>Advanced Micro Devices</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/amd-stock-quote/"><strong>AMD</strong></a>): Back in June 2015, AMD traded for below $2.</li>
</ul><p>Of course, there are way more failures than successes. But if you want to go for gold, below are the OTC stocks to consider.</p>



<h2>Tencent (TCEHY)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/tcehy-stock-3-300x169.jpg" alt="Tencent (TCEHY) sign on Tencent headquarters in Shenzhen, China."><div>Source: StreetVJ / Shutterstock.com</div></div>


<p>A Chinese multinational technology conglomerate, <strong>Tencent</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/tcehy-stock-quote/"><strong>TCEHY</strong></a>) has had a rough outing in 2023. Mainly, that&rsquo;s due to the challenging circumstances surrounding the Chinese economy. And if a <em>CNN</em> report proves correct, 2024 <a href="https://www.cnn.com/2023/12/27/economy/china-economy-challenges-2024-intl-hnk/index.html">could be an even rougher outing</a>. Still, Tencent&rsquo;s <a href="https://www.reuters.com/technology/tencent-reveals-most-ambitious-game-yet-consoles-amid-global-expansion-2023-12-08/">expansionary ambitions</a> reach beyond its home nation. With eyes on Japan, South Korea, Southeast Asia, and <a href="https://www.prnewswire.com/apac/news-releases/tencent-cloud-highlights-collaborative-global-expansion-with-digital-ecological-partners-at-tencent-cloud-digital-ecosystem-summit-2023-global-connect-session-301921841.html#:~:text=Fred%20Sun%2C%20General%20Manager%20of,East%2C%20providing%20solutions%20for%20various">several other international regions</a>, Tencent could be interesting for speculators.</p>



<p>To be sure, with a market capitalization of around $337.5 billion, TCEHY doesn&rsquo;t exactly rate as one of the typical OTC stocks. However, it&rsquo;s a great confidence booster because it&rsquo;s in some ways the best of both worlds: offering tremendous upside potential while also being a technology stalwart in its home nation.</p>



<p>Analysts rate shares a <a href="https://www.tipranks.com/stocks/tcehy">consensus moderate buy</a> with a $49.56 average price target. That implies an upside potential of over 40%. What&rsquo;s more, the high-side target hits $61.13, possibly delivering growth of over 73%. If that wasn&rsquo;t enough to whet your appetite, shares <a href="https://www.gurufocus.com/stock/TCEHY/summary?search=tcehy">trade at only 13.06X forward earnings</a>, below the interactive media sector&rsquo;s median value of 21.19X.</p>



<h2>BYD (BYDDF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/09/byddf-stock-1-300x169.jpg" alt="A close-up view of the power supply plugged into a vehicle from BYD Company (BYDDY)."><div>Source: J. Lekavicius / Shutterstock.com</div></div>


<p>Moving on to another Chinese company, <strong>BYD</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/byddf-stock-quote/"><strong>BYDDF</strong></a>) presents a unique proposition. First, it&rsquo;s a major automotive enterprise specializing in electric vehicles, yet it technically ranks among the OTC stocks. Second, Warren Buffett &ndash; who is best known for investing in reliable blue chips &ndash; <a href="https://www.cnbc.com/berkshire-hathaway-portfolio/">owns BYD</a> via <strong>Berkshire Hathaway</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/brk-b-stock-quote/"><strong>BRK-B</strong></a></span>). To be fair, Buffett has been <a href="https://apnews.com/article/berkshire-hathaway-warren-buffett-byd-397410cefd128f283c5efcc7cf90c1fa">reducing his exposure</a> but he still owns a sizable amount.</p>



<p>Despite the seemingly contradictory tone, investors may want to consider adding BYDDF to their portfolio. Yeah, it&rsquo;s one of the OTC stocks and yes, the Chinese economy looks rather putrid if I&rsquo;m being honest. However, with EVs becoming increasingly commoditized, guess who&rsquo;s going to win that battle? There&rsquo;s just no way that western nations can compete with their higher labor costs.</p>



<p>Also, investors should consider another element: demand. European politicians may want to reduce the flood of Chinese EVs. But their constituents? They love &lsquo;em. So do analysts, who rate BYDDF a <a href="https://www.tipranks.com/stocks/byddf/forecast">consensus strong buy</a> with a $36.03 price target. That implies 63% upside potential.</p>



<h2>Xiaomi (XIACF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/05/electric-vehicle-charger1600-300x169.png" alt="Power supply connect to electric vehicle for charge to the battery. Charging technology industry transport which are the futuristic of the Automobile. EV fuel Plug in hybrid car."><div>Source: buffaloboy / Shutterstock.com</div></div>


<p>Yet one more Chinese company to discuss and then we&rsquo;ll get into the really wild OTC stocks. A designer and manufacturer of consumer electronics and related software, <strong>Xiaomi</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/xiacf-stock-quote/"><strong>XIACF</strong></a>) is a cynical play. For example, beyond its consumer electronics business, it&rsquo;s also involved in the EV space. Recently, the company <a href="https://www.cnbc.com/2023/12/28/chinas-xiaomi-unveils-first-ev-in-bid-to-compete-with-porsche-tesla.html">launched its first electric-powered vehicle</a>, which might have caught the eyes of some lawyers.</p>



<p>I&rsquo;m joking there, but seriously, the <a href="https://www.mi.com/global/discover/article?id=3095&amp;ref=upstract.com">Xiaomi SU7</a> looks like it ripped off the design of a particular German brand. But if the consumers who love BYD offer any clues, the SU7 should be a hit. Apparently, it has the performance (<a href="https://www.topspeed.com/xiaomi-su7-ev-facts/#:~:text=Performance%20Specifications&amp;text=The%20SU7%20Max%20trim%20will,top%20speed%20of%20165%20mph.">up to 664 horsepower</a>) and the longevity to <a href="https://www.carscoops.com/2023/12/xiaomis-su7-will-outrun-a-taycan-and-outlast-a-tesla-model-s/">better the top players in the ecosystem</a>. And even if you didn&rsquo;t like the EV pivot, Xiaomi should win in consumer electronics.</p>



<p>Frankly, with smart devices becoming so commoditized, people may start looking to price more often than brand. If so, XIACF has a clear pathway to robust shareholder profits. Analysts agree, rating the stock a <a href="https://www.tipranks.com/stocks/xiacf/forecast">unanimous strong buy</a> with a $2.66 average price target.</p>



<h2>Quisitive Technology Solutions (QUISF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/cloud1600d-300x169.jpg" alt=""><div>Source: Shutterstock</div></div>


<p>Okay, let&rsquo;s buckle up for some serious OTC stocks and by that, I mean high risk, high reward. First, <strong>Quisitive Technology Solutions</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/quisf-stock-quote/"><strong>QUISF</strong></a>) bills itself as a premier global <strong>Microsoft</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/msft-stock-quote/"><strong>MSFT</strong></a>) partner that harnesses its cloud platforms and complete technologies to generate transformational impact for midsize and enterprise-level customers. It&rsquo;s an intriguing idea because, at one point, shares closed at $1.54 on a weekly average basis.</p>



<p>Currently, QUISF trades hands at only 22 cents. And you should note that over the past 52 weeks, it lost more than 53% of its equity value. Further, according to the security&rsquo;s point-and-figure (P&amp;F) chart, it prints a double bottom breakdown. According to StockCharts.com&rsquo;s educational section, this pattern is a bearish signal. That said, the pattern should also be viewed in a <a href="https://school.stockcharts.com/doku.php?id=chart_analysis:pnf_charts:pnf_bearish_bd#:~:text=for%20price%20objectives.-,Double%20Bottom%20Breakdown,These%20patterns%20are%20not%20contradictory.">broader context</a> due to possible whipsaw effects.</p>



<p>And what is that context? Basically, the broader cloud computing market <a href="https://www.fortunebusinessinsights.com/cloud-computing-market-102697">could be worth $2.43 trillion</a> by 2030. Quisitive just needs to take a bite out of this market to potentially drive higher. Analysts seem to be on the same page, pegging the <a href="https://www.tipranks.com/stocks/quisf/forecast">average price target at 49 cents</a>.</p>



<h2>Peninsula Energy (PENMF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/uranium1600-300x169.jpg" alt="periodic table concept with black cubes. uranium element is glowing. Uranium stocks"><div>Source: Shutterstock</div></div>


<p>As a fan of the uranium energy space, I perked up when I came across this opportunity hidden among OTC stocks. As a uranium extraction specialist, <strong>Peninsula Energy</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/penmf-stock-quote/"><strong>PENMF</strong></a>) addresses a critical supply shortage that recently sprouted. According to <em>The Wall Street Journal</em>, last month, <a href="https://www.wsj.com/finance/commodities-futures/uranium-prices-jump-to-16-year-high-on-supply-woes-analysis-05c7086f">uranium prices jumped to a 16-year high</a> after one of the world&rsquo;s largest producers &ndash; Kazakhstan&rsquo;s state-owned company <strong>Kazatomprom</strong> &ndash; warned of production target shortfalls.</p>



<p>With uranium supplies uncertain for the next two years, several uranium players have skyrocketed. One of the exceptions is PENMF. In the trailing one-year period, the security declined by 8%. That said, it is up 15% on a year-to-date basis but that&rsquo;s a modest performance compared to exchange-listed uranium specialists.</p>



<p>Still, as far as OTC stocks are concerned, Peninsula could be intriguing because of geopolitical considerations. Basically, it features 100% ownership of the Lance Project, which is one of the largest uranium projects in the U.S.</p>



<p>Better yet, analysts expect great things, pegging shares a moderate buy with a 17-cent target. That implies almost 85% upside potential, with the high-side target landing at 22 cents.</p>



<h2>Saturn Oil &amp; Gas (OILSF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/03/oilandgasstocks1600-300x169.png" alt="Panorama of Oil and Gas central processing platform in twilight, offshore hard work occupation twenty four working hours. Best oil stocks to buy"><div>Source: Oil and Gas Photographer / Shutterstock.com</div></div>


<p>Based in Calgary, Alberta, Canada, <strong>Saturn Oil &amp; Gas</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/oilsf-stock-quote/"><strong>OILSF</strong></a>) is a resource company engaged in the business of acquisition, exploration and development of petroleum and natural gas resource despoits in Western Canada. Further, the company&rsquo;s current focus is to advance the exploration and development of its oil and gas properties in Alberta and Saskatchewan.</p>



<p>As an upstream player in the hydrocarbon space, Saturn might not seem particularly relevant. Late last year, many oil-producing nations <a href="https://www.cnn.com/2023/11/30/energy/saudi-arabia-extend-production-cut-opec/index.html">agreed to cut production in a bid to bolster prices</a>. However, that effort did not succeed. Also, <em>Reuters</em> recently reported that rising U.S. oil production has <a href="https://www.reuters.com/markets/commodities/rising-us-oil-production-frustrates-opec-cuts-kemp-2024-02-01/">frustrated the aforementioned oil producers</a>. So, it seems OILSF could be one of the losing OTC stocks.</p>



<p>However, the blowout <a href="https://finance.yahoo.com/news/january-jobs-report-us-economy-adds-353000-jobs-blowing-past-wall-street-expectations-133251408.html">January jobs report</a> suggests that we shouldn&rsquo;t quite give up on black gold just yet. More people with jobs should translate to more resource consumption. And to be blunt, renewable energy just won&rsquo;t be enough to feed the growing demand profile. Notably, Echelon Wealth Partners believes OILSF <a href="https://www.tipranks.com/stocks/oilsf/forecast">could hit $4.22 per share or 137% up</a>.</p>



<h2>Vivos (RDGL)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/medical-bills-1600-300x169.png" alt="Doctor or physician calculating a patients medical bills at a desk. Medical bills, health costs, health expenses."><div>Source: THICHA SATAPITANON / Shutterstock</div></div>


<p>Before discussing radiation oncology medical device firm <strong>Vivos</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/rdgl-stock-quote/"><strong>RDGL</strong></a>), it&rsquo;s important to disclose that I own RDGL stock. Please make a decision based on your own due diligence and a sober reflection of your risk tolerance. This is a security that has already lost almost 28% YTD and is likely subject to severe market turbulence.</p>



<p>With the caveats out of the way, Vivos is engaged in the development of its <a href="https://www.radiogel.com">yttrium-90-based brachytherapy device, RadioGel</a>, for the treatment of non-resectable tumors. According to Johns Hopkins Medicine, brachytherapy is a <a href="https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/brachytherapy">radiation treatment</a> that is given directly into the patient&rsquo;s body. Typically, the radiation is deployed using tiny devices such as wires, seeds, or rods filled with radioactive materials.</p>



<p>Where Vivos distinguishes itself is that RadioGel utilizes an injectable particle-gel, which delivers a very high local radiation dose. More broadly, RDGL entices speculators because the underlying industry is still in its early innings, <a href="https://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market">worth $907.76 million in 2022</a>.</p>



<p>As for a price target, it&rsquo;s difficult to say as no analyst currently covers RDGL. However, <a href="https://upperdeckoptions.com/2024/01/31/rdgl-stock-a-potential-sentiment-shift-in-2023/">based on my personal research</a>, I believe around 5 cents is the bottom.</p>



<p><strong><a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a></strong></p>



<p><strong><em>On Penny Stocks and Low-Volume Stocks:</em></strong><em>&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&nbsp;<a href="http://investorplace.com/">InvestorPlace.com</a>&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em>Read More:&nbsp;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Josh Enomoto</em><em>&nbsp;held a LONG position in&nbsp;RDGL. </em><em>The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<div><p>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/02/high-risk-high-reward-7-otc-stocks-that-could-make-you-rich-this-year/">High-Risk, High-Reward: 7 OTC Stocks That Could Make You Rich This Year</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

High-Risk, High-Reward: 7 OTC Stocks That Could Make You Rich This Year

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>If you want millionaire-maker stocks, go consult Warren Buffett. The Oracle of Omaha has plenty of compelling ideas. However, if you want to reach millionaire status quickly, you&rsquo;re going to need to dial up the risk factor.</p>



<p>Here, the narrative is quite simple. If you want to give yourself a realistic possibility &ndash; note I didn&rsquo;t say probability &ndash; of winning big, you&rsquo;ve got to target extremely speculative market ideas. Usually, that means <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> or shares that are priced so low they can benefit from the law of small numbers.</p>



<p>However, once the initial liftoff is achieved, the beneficiary enterprises need attractive businesses to keep the fire burning. Arguably, the below companies have exactly that &ndash; but you better be prepared for extreme volatility. On that note, take a look at these millionaire-maker stocks.</p>



<h2>Knightscope (KSCP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/kscp-stock-300x169.png" alt="An image of a Knightscope, Inc. (KSCP) robot in a parking garage"><div>Source: Sundry Photography / Shutterstock.com</div></div><p>Billed as a security camera and robotics firm, <strong>Knightscope</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/kscp-stock-quote/"><strong>KSCP</strong></a>) designs, builds, and deploys robots called <a href="https://www.knightscope.com">Autonomous Data Robots</a>. This solution allows for the monitoring of people in malls, parking lots, neighborhoods, and other public areas. Fundamentally, the main positive catalyst for KSCP stock centers on security.</p>



<p>As a Californian, one news item caught my eye: the popular In-N-Out Burger will <a href="https://apnews.com/article/oakland-innout-burger-closing-crime-9cd8f43eb43fe781086b9e277eb0724d#:~:text=January%2026%2C%202024-,OAKLAND%2C%20Calif.,only%20restaurant%20in%20Oakland%2C%20California.">close its first location</a> in its 75-year history in Oakland. To the chagrin of residents, a wave of car break-ins, property damage, theft, and robberies affecting both customers and employees took their toll on the business. It&rsquo;s incidents like this multiplied at a scale that demonstrates the forward viability of KSCP as one of the millionaire-maker stocks.</p>



<p>To be sure, Knightscope carries significant risks, including <a href="https://www.gurufocus.com/stock/KSCP/analysis/warning-signs">several severe ones</a>, per investment data aggregator Gurufocus. Still, after a rough patch in getting the business moving, the company has printed encouraging <a href="https://www.gurufocus.com/stock/KSCP/financials">revenue growth</a> recently.</p>



<p><a href="https://www.businesswire.com/news/home/20240104703804/en/Ascendiant-Capital-Markets-Maintains-Buy-Rating-for-Knightscope-Raises-Per-Share-Price-Target-to-4.00">Ascendiant&rsquo;s Edward Woo believes shares can hit $4</a>. If so, we&rsquo;re talking upside potential of over 692%.</p>



<h2>Quantum Computing (QUBT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/09/quantum-computing-3-300x169.jpg" alt="A concept image showing a quantum computer with a matrix background; quantum computing. leading quantum stocks, quantum computing stocks to buy"><div>Source: Shutterstock</div></div><p>I love companies that explain what they do just with their title. Here on this list of millionaire-maker stocks, we have <strong>Quantum Computing</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/qubt-stock-quote/"><strong>QUBT</strong></a>). It doesn&rsquo;t get much more direct than that. In all seriousness, the company is pioneering the production of photonic hardware solutions using non-linear quantum optics. This innovation should allow exponential acceleration in computing, machine learning, cybersecurity and other advanced fields.</p>



<p>According to Fortune Business Insights, the market itself is relatively small, landing at only $928.8 million last year. However, it&rsquo;s expanding at a tremendous clip; a compound annual growth rate (CAGR) of 32.1% to 2030, per analysts&rsquo; projections. If that rate holds true, the quantum computing sector <a href="https://www.fortunebusinessinsights.com/quantum-computing-market-104855#:~:text=The%20quantum%20computing%20market%20size,share%20of%2042.97%25%20in%202022.">could be worth approximately $6.53 billion</a>.</p>



<p>For context, QUBT stock only printed a market capitalization of just under $59 million. So, if the stars align, Quantum could easily rank among the millionaire-maker stocks.</p>



<p>Sure enough, <a href="https://finance.yahoo.com/news/7-analyst-backed-stocks-promising-000957206.html">Ascendiant&rsquo;s Woo also endorses QUBT, targeting $8.75</a> or around 1,015% up from Wednesday&rsquo;s close.</p>



<h2>Vivos (RDGL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/biomedical-technology1600-300x169.png" alt="Modern Medical Research Laboratory with Computer, Microscope, Glassware with Biochemicals on the Desk. Scientific Lab Biotechnology Development Center Full of High-Tech Equipment. Biomedical technology stocks, RSLS Stock"><div>Source: Gorodenkoff / Shutterstock.com</div></div><p>If you want to know what a dedicated fanbase for a publicly traded security looks like, <a href="https://twitter.com/EnomotoMedia">check out my X account</a>. Here, you&rsquo;re going to find plenty of discussions and expressions of adoration for medical technology firm <strong>Vivos</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/rdgl-stock-quote/"><strong>RDGL</strong></a>). Yes, it&rsquo;s traded over the counter. Yes, it&rsquo;s a six-cent stock. No, it&rsquo;s not something out of the movie &ldquo;The Wolf of Wall Street.&rdquo;</p>



<p>Instead, what we have here is a radiation oncology specialist. Focusing on an advanced form of brachytherapy, Vivos utilizes radioactive materials (yttrium-90) to directly implement a high-dose treatment to the target area while imposing a minimal dosage to surrounding healthy tissue. Brachytherapy is already a promising therapeutic approach, which should see a 7.1% CAGR <a href="https://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market">to land at a value of $1.62 billion by 2030</a>.</p>



<p>Here&rsquo;s what&rsquo;s really intriguing about Vivos: it improves upon brachytherapy through a minimally invasive procedure that leverages a hydrogel solution to deliver the cancer-fighting therapeutic. Following the implementation, the hydrogel is safely absorbed by the body. Vivos appears unique in its brachytherapy-based approach. Therefore, I have personally put my money where my mouth is here.</p>



<p><strong><em>On Penny Stocks and Low-Volume Stocks:&#8239;</em></strong><em>With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.</em></p>



<p><strong><em>Read More:&#8239;</em></strong><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>Penny Stocks &mdash;&nbsp;How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Josh Enomoto</em><em>&nbsp;held a LONG position in RDGL. </em><em>The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<div><p>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/02/3-stocks-to-turn-1000-into-1-million-february-2024/">3 Stocks to Turn $1,000 Into $1 Million: February 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Stocks to Turn $1,000 Into $1 Million: February 2024

Vivos Inc (RDGL) has issued an update. Vivos, Inc. has renewed its Executive Employment Agreement with CEO Dr. Michael Korenko, effective January 1...

Vivos Inc Secures Leadership Continuity with CEO Contract Renewal

Catalyst Watch: Disney earnings, Apple iPad event and Fed speakers back on the circuit

AAPL

ABNB

AFRM

AMCX

ASCUF

AZTR

BYDDF

BYND

CABA

COST

CPNG

CPRI

CRSP

DCPH

DDOG

EDIT

FGEN

KNSL

KOPN

KSCP

LAZR

MBLY

MCBC

MNST

MSFT

NDAQ

NISTF

NKLA

NRGV

OILSF

PENMF

PLTR

QUBT

QUISF

RACE

RBLX

RDDT

RDGL

REGN

RIVN

SAVE

SHOP

SNAP

TCEHY

TSLA

UBER

UPST

USFD

VRTX

VSTO

VZIO

XIACF

ZYXI

Screenshot 2024-07-01 at 8.57.06 AM

Biotech

General

Vivos One Step Closer To Transforming Cancer Treatment With FDA Application To Start Human Trials For Pioneering Injectable Brachytherapy Device

Press Releases

Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation

Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials

Vivos Inc. Provides IDE Submission Status Update – Conversion to Pre-Sub Filing Accepted by the FDA

Vivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM to Exotics

Vivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM

Vivos

Comments

Vivos

Vivos (RDGL) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO